Nanopharmaceutics

Alachua, United States Founded: 2002 • Age: 24 yrs
Discovers and develops therapeutic products for cancer, CNS disorders, and infectious diseases.

About Nanopharmaceutics

Nanopharmaceutics is a company based in Alachua (United States) founded in 2002. It operates as a B2B. Nanopharmaceutics offers products and services including Triapine, ATTM, Aza-TdCyd, NanoBUP, and PRX-3140. Nanopharmaceutics operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.

  • Headquarter Alachua, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Nanopharmaceutics, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Nanopharmaceutics

Nanopharmaceutics offers a comprehensive portfolio of products and services, including Triapine, ATTM, Aza-TdCyd, NanoBUP, and PRX-3140. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Targeted drug for cancer treatment and patient outcomes.

Developed for specific disorders in the product pipeline.

Focuses on infectious diseases treatment applications.

Innovative product for CNS disorder management.

Targets diseases in the company's development pipeline.

Part of therapeutics for various medical conditions.

Supports targeted treatment development efforts.

Aimed at infectious disease interventions.

Contributes to the company's drug innovation pipeline.

Funding Insights of Nanopharmaceutics

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Nanopharmaceutics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Nanopharmaceutics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Nanopharmaceutics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Nanopharmaceutics

Nanopharmaceutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Novel biopharmaceutical medicines are developed for unmet medical needs.
domain founded_year HQ Location
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
domain founded_year HQ Location
Small molecule therapeutics for cancer treatment are developed.
domain founded_year HQ Location
MicroRNA-based therapeutics are developed for treating multiple diseases.
domain founded_year HQ Location
Therapeutics for cancer and rare diseases are developed.
domain founded_year HQ Location
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Nanopharmaceutics

When was Nanopharmaceutics founded?

Nanopharmaceutics was founded in 2002.

Where is Nanopharmaceutics located?

Nanopharmaceutics is headquartered in Alachua, United States. It is registered at Alachua, Florida, United States.

What does Nanopharmaceutics do?

Nanopharmaceutics, Inc. is a biotechnology company that discovers and develops targeted therapeutic products for treating cancer, central nervous system disorders, and infectious diseases. It operates a product pipeline including drugs like Triapine and NanoBUP. Based in Alachua, Florida, as a subsidiary of TRON Group Inc., the company focuses on innovative drug development to address unmet medical needs.

Who are the top competitors of Nanopharmaceutics?

Nanopharmaceutics's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.

What products or services does Nanopharmaceutics offer?

Nanopharmaceutics offers Triapine, ATTM, Aza-TdCyd, NanoBUP, and 5 more products and services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available